Published in Cell Tissue Res on March 01, 1987
Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med (1994) 5.78
New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun (1991) 2.14
Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol (1989) 1.82
Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. Clin Exp Immunol (1989) 1.79
Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med (1996) 1.75
Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun (1993) 1.52
Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine (2006) 1.38
Peyer's Patches: The Immune Sensors of the Intestine. Int J Inflam (2010) 1.32
Defense mechanisms in Peyer's patches and mesenteric lymph nodes against Yersinia enterocolitica involve integrins and cytokines. Infect Immun (1996) 1.28
Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection. Infect Immun (1992) 1.19
M cell-targeted DNA vaccination. Proc Natl Acad Sci U S A (2001) 1.10
Intestinal M cells: the fallible sentinels? World J Gastroenterol (2007) 1.05
Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest (2010) 1.04
Human intestinal M cells display the sialyl Lewis A antigen. Infect Immun (1999) 1.01
Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells. Immunology (1991) 0.97
Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis. Infect Immun (1991) 0.90
Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection. Infect Immun (1996) 0.88
Phenotypically distinct subpopulations of T cells in domes and M-cell pockets of rabbit gut-associated lymphoid tissues. Immunology (1990) 0.88
Activation of cholera toxin-specific T cells in vitro. Infect Immun (1990) 0.88
Antigen sampling by intestinal M cells is the principal pathway initiating mucosal IgA production to commensal enteric bacteria. Mucosal Immunol (2015) 0.87
Orally administered microencapsulated reovirus can bypass suckled, neutralizing maternal antibody that inhibits active immunization of neonates. J Virol (1997) 0.86
Use of lectin-functionalized particles for oral immunotherapy. Ther Deliv (2012) 0.85
Improving M cell mediated transport across mucosal barriers: do certain bacteria hold the keys? Immunology (2004) 0.85
The uptake of soluble and particulate antigens by epithelial cells in the mouse small intestine. PLoS One (2014) 0.84
Differential intestinal M-cell gene expression response to gut commensals. Immunology (2012) 0.83
Importance of gastrointestinal ingestion and macromolecular antigens in the vein for oral tolerance induction. Immunology (2006) 0.82
Ultrastructural characteristics and lectin-binding properties of M cells in the follicle-associated epithelium of chicken caecal tonsils. J Anat (2000) 0.81
M cells and granular mononuclear cells in Peyer's patch domes of mice depleted of their lymphocytes by total lymphoid irradiation. Am J Pathol (1989) 0.80
Roles of M cells in infection and mucosal vaccines. Hum Vaccin Immunother (2014) 0.79
Human intestinal M cells exhibit enterocyte-like intermediate filaments. Gut (1998) 0.78
Peyer's patches: organizing B-cell responses at the intestinal frontier. Immunol Rev (2016) 0.76
M cells are involved in pathogenesis of human contact lens-associated giant papillary conjunctivitis. Arch Immunol Ther Exp (Warsz) (2007) 0.75
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys (2000) 7.50
Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature (1995) 5.42
More on managing metastatic choroidal tumors. Oncology (Williston Park) (1989) 5.12
Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun (1992) 2.66
Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect Immun (1994) 2.56
Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun (1997) 2.49
Molecular and cellular basis of immune protection of mucosal surfaces. Physiol Rev (1992) 2.39
Epithelial M cells: differentiation and function. Annu Rev Cell Dev Biol (2000) 2.36
Direct measurement of critical concentrations and assembly rate constants at the two ends of an actin filament. Cell (1983) 2.31
New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun (1991) 2.14
Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys (1993) 2.13
Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: role of vesicular traffic. J Cell Biol (1992) 2.00
Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res (1993) 1.99
Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol (1995) 1.96
The role of pili and capsule in the pathogenesis of neonatal infection with Escherichia coli K1. J Infect Dis (1983) 1.95
Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect Immun (2000) 1.94
Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys (1997) 1.93
Transepithelial transport of HIV-1 by intestinal M cells: a mechanism for transmission of AIDS. J Acquir Immune Defic Syndr (1991) 1.85
Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. Gastroenterology (1994) 1.85
Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol (1989) 1.82
Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J Exp Med (1996) 1.75
Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg (1994) 1.72
Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys (1995) 1.71
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1998) 1.71
Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys (1994) 1.70
Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol (1997) 1.67
Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. J Acquir Immune Defic Syndr (2000) 1.65
Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am (1998) 1.63
A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys (1991) 1.63
RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys (1995) 1.57
High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (1990) 1.56
Acetylation (O-factor 5) affects the structural and immunological properties of Salmonella typhimurium lipopolysaccharide O antigen. Infect Immun (1995) 1.52
Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun (1993) 1.52
Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys (1999) 1.50
Mechanism of rapid mucus secretion in goblet cells stimulated by acetylcholine. J Cell Biol (1980) 1.48
Failure of preenucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol (1988) 1.42
Glycoprotein synthesis, transport, and secretion by epithelial cells of human rectal mucosa: normal and cystic fibrosis. Lab Invest (1977) 1.42
Membrane-bound and fluid-phase macromolecules enter separate prelysosomal compartments in absorptive cells of suckling rat ileum. J Cell Biol (1984) 1.42
Localization and dynamics of nonfilamentous actin in cultured cells. J Cell Biol (1993) 1.41
Vision following helium ion radiotherapy of uveal melanoma: a Northern California Oncology Group study. Int J Radiat Oncol Biol Phys (1988) 1.39
Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys (1994) 1.34
A Carboniferous insect gall: insight into early ecologic history of the Holometabola. Proc Natl Acad Sci U S A (1996) 1.34
Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am J Physiol (1994) 1.32
The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol (1978) 1.31
Intestinal goblet cell mucus release. II. In vivo stimulation by antigen in the immunized rat. J Immunol (1979) 1.29
Intracellular transport of transferrin- and asialoorosomucoid-colloidal gold conjugates to lysosomes after receptor-mediated endocytosis. J Histochem Cytochem (1985) 1.27
Adherence of Salmonella typhimurium to Caco-2 cells: identification of a glycoconjugate receptor. Infect Immun (1996) 1.27
Desmoid tumors--treatment and prognosis. Radiology (1977) 1.26
Economic evaluation of interventions to reduce road traffic injuries--a review of the literature with applications to low and middle-income countries. Asia Pac J Public Health (2004) 1.26
Proteolytic processing of reovirus is required for adherence to intestinal M cells. J Virol (1994) 1.26
Functional diversity among spectrin isoforms. Cell Motil Cytoskeleton (1989) 1.25
Altered hepatic transport of immunoglobulin A in mice lacking the J chain. J Exp Med (1995) 1.24
Soft tissue sarcomas of the extremities: survival and patterns of failure with conservative surgery and postoperative irradiation compared to surgery alone. Cancer (1982) 1.24
Transcytosis of the polymeric Ig receptor requires phosphorylation of serine 664 in the absence but not the presence of dimeric IgA. Cell (1993) 1.23
Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery (1995) 1.21
An ultrastructural study of the development of radiation injury in the lung. Radiology (1966) 1.21
Use of transgenic mice to study the routing of secretory proteins in intestinal epithelial cells: analysis of human growth hormone compartmentalization as a function of cell type and differentiation. J Cell Biol (1989) 1.20
Human intestinal goblet cells in monolayer culture: characterization of a mucus-secreting subclone derived from the HT29 colon adenocarcinoma cell line. Gastroenterology (1988) 1.19
Monoclonal immunoglobulin A antibodies directed against cholera toxin prevent the toxin-induced chloride secretory response and block toxin binding to intestinal epithelial cells in vitro. Infect Immun (1993) 1.19
Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation (1996) 1.19
Brush border cytoskeleton and integration of cellular functions. J Cell Biol (1984) 1.19
Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation (1995) 1.18
A calsequestrin-like protein in the endoplasmic reticulum of the sea urchin: localization and dynamics in the egg and first cell cycle embryo. J Cell Biol (1989) 1.18
Functional expression of the polymeric immunoglobulin receptor from cloned cDNA in fibroblasts. J Cell Biol (1986) 1.17
Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches. J Virol (2001) 1.17
Identification of an endosomal antigen specific to absorptive cells of suckling rat ileum. J Cell Biol (1987) 1.17
Desmoid tumors: local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys (1983) 1.17
Kidney cell proliferation after unilateral nephrectomy as related to age. Cancer Res (1967) 1.16
Regulation of intestinal goblet cell secretion. II. A survey of potential secretagogues. Am J Physiol (1982) 1.16
Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival. Cancer Res (1980) 1.16
Modification of radiation injury to normal tissues by chemotherapeutic agents. Cancer (1975) 1.15
Malignant tumors of the testis: analysis of treatment results and sites and causes of failure. Cancer (1977) 1.14
Junctional complexes in fetal rat small intestine during morphogenesis. Dev Biol (1981) 1.13
Lack of association of secretory component with IgA in J chain-deficient mice. J Immunol (1996) 1.13
Radiation retinopathy. Int J Radiat Oncol Biol Phys (1979) 1.12
The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol (1980) 1.12
Membrane interactions between adjacent mucols secretion granules. J Cell Biol (1977) 1.10
Regulation of intestinal goblet cell secretion. III. Isolated intestinal epithelium. Am J Physiol (1984) 1.10
Radiation response of artificial pulmonary metastases of the EMT6 tumor. Int J Radiat Oncol Biol Phys (1976) 1.08
Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res (1994) 1.08
Cholera toxin, E. coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches. Mucosal Immunol (2008) 1.08
High intensity 125-iodine (125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys (1993) 1.07
Defining treatment margins for six field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys (1994) 1.07
Stereotaxic irradiation of brain tumors. Cancer (1990) 1.07
Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys (1979) 1.06
Transepithelial transport of epidermal growth factor by absorptive cells of suckling rat ileum. J Clin Invest (1987) 1.06
Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer (1977) 1.05
Prognostic factors in adult soft-tissue sarcomas of the head and neck. Int J Radiat Oncol Biol Phys (1997) 1.05
Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques. Am J Pathol (2000) 1.05
Prokaryotic-eukaryotic cell junctions: attachment of spirochetes and flagellated bacteria to primate large intestinal cells. J Ultrastruct Res (1980) 1.04
Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721. Cancer Clin Trials (1981) 1.04
Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer (1976) 1.04
Time-dose relationships in the mouse esophagus. Radiology (1974) 1.03
Spatial and temporal dynamics of the secretory pathway during differentiation of the Plasmodium yoelii schizont. Mol Biochem Parasitol (2000) 1.03
Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys (1989) 1.03
Radiation pneumonitis: a new approach to the derivation of time-dose factors. Cancer (1973) 1.02
Neon ion radiotherapy: results of the phase I/II clinical trial. Int J Radiat Oncol Biol Phys (1991) 1.02
Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J Urol (1996) 1.02
Contributions of the beta-subunit to spectrin structure and function. Cell Motil Cytoskeleton (1989) 1.01